Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
15.20
-0.86 (-5.35%)
At close: May 7, 2026, 4:00 PM EDT
15.20
0.00 (0.00%)
After-hours: May 7, 2026, 5:02 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.69 billion as of May 7, 2026. Its market cap has increased by 287.34% in one year.
Market Cap
1.69B
Enterprise Value
1.41B
1-Year Change
287.34%
Ranking
Category
Stock Price
$15.20
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.69B, an increase of 57.92%. That is a compound annual growth rate of 11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.78B | 34.48% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Consumer Healthcare | 2.57B |
| Phibro Animal Health | 2.37B |
| HUTCHMED (China) | 2.32B |
| BioCryst Pharmaceuticals | 2.24B |
| Bausch Health Companies | 2.11B |
| ANI Pharmaceuticals | 1.91B |
| Perrigo Company | 1.69B |
| Harrow | 1.50B |